1. Pulliam, Thomas L, Goli, Pavithr, Awad, Dominik, Wilkenfeld, Sandi R, Frigo, Daniel E. 2022. Regulation and role of CAMKK2 in prostate cancer. In Nature reviews. Urology, 19, 367-380. doi:10.1038/s41585-022-00588-z. https://pubmed.ncbi.nlm.nih.gov/35474107/
2. Jin, Lingtao, Chun, Jaemoo, Pan, Chaoyun, Owonikoko, Taofeek K, Kang, Sumin. 2017. The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer. In Molecular cell, 69, 87-99.e7. doi:10.1016/j.molcel.2017.11.025. https://pubmed.ncbi.nlm.nih.gov/29249655/
3. Mével, E, Shutter, J A, Ding, X, Burr, D B, Sankar, U. 2021. Systemic inhibition or global deletion of CaMKK2 protects against post-traumatic osteoarthritis. In Osteoarthritis and cartilage, 30, 124-136. doi:10.1016/j.joca.2021.09.001. https://pubmed.ncbi.nlm.nih.gov/34506942/
4. Luo, X-J, Li, M, Huang, L, Su, B, Gan, L. 2013. Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. In Molecular psychiatry, 19, 774-83. doi:10.1038/mp.2013.103. https://pubmed.ncbi.nlm.nih.gov/23958956/
5. Huang, Yu-Kai, Su, Yu-Feng, Lieu, Ann-Shung, Kuo, Keng-Liang, Lin, Chih-Lung. 2020. MiR-1271 regulates glioblastoma cell proliferation and invasion by directly targeting the CAMKK2 gene. In Neuroscience letters, 737, 135289. doi:10.1016/j.neulet.2020.135289. https://pubmed.ncbi.nlm.nih.gov/32791096/
6. Lin, Fumin, Marcelo, Kathrina L, Rajapakshe, Kimal, Means, Anthony R, York, Brian. 2015. The camKK2/camKIV relay is an essential regulator of hepatic cancer. In Hepatology (Baltimore, Md.), 62, 505-20. doi:10.1002/hep.27832. https://pubmed.ncbi.nlm.nih.gov/25847065/